Artificial Intelligence in Drug Development Congress

Oxford Global Conferences are proud to present the Artificial Intelligence in Drug Development Congress co-located with our 15th Annual Pharmaceutical IT Congress, taking place on the 27-28 September 2017 in London. Over 250 artificial intelligence and pharmaceutical IT attendees representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions. Over 20 presentations, case studies and panel discussions focussed on the innovative application of artificial intelligence in drug development and clinical research, alongside novel diagnostic tools using artificial intelligence. Including 3 Interactive Streams: • Artificial Intelligence (AI) in Drug Discovery and Development • Artificial Intelligence (AI) in Big Data and Clinical Research Development • Diagnostics and Medical Imaging in Healthcare 14 pre-scheduled one to one meetings, exhibition and informal networking opportunities. Free Pre-Congress Webinars ... Read more

Oxford Global Conferences are proud to present the Artificial Intelligence in Drug Development Congress co-located with our 15th Annual Pharmaceutical IT Congress, taking place on the 27-28 September 2017 in London. Over 250 artificial intelligence and pharmaceutical IT attendees representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions. Over 20 presentations, case studies and panel discussions focussed on the innovative application of artificial intelligence in drug development and clinical research, alongside novel diagnostic tools using artificial intelligence. Including 3 Interactive Streams: • Artificial Intelligence (AI) in Drug Discovery and Development • Artificial Intelligence (AI) in Big Data and Clinical Research Development • Diagnostics and Medical Imaging in Healthcare 14 pre-scheduled one to one meetings, exhibition and informal networking opportunities. Free Pre-Congress Webinars Harnessing AI and Big Data in Drug Discovery Hosted by Ed Addison, CEO, Cloud Pharmaceuticals Coming soon. The Impact of Structure Based Drug Design and Computational Analysis on the Timeframes of Drug Development Hosted by Rafael Depetris, Principal Scientist I, Kadmon Corporation Download today, for free: http://bit.ly/2rkxImn Can’t make the date? Still register and a copy of the recording will be sent to you. For further information on how to register and what discounts are available to your company, please contact Angela Fernandez Saez on a.fernandez@oxfordglobal.co.uk